We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Massive Novartis OTC Drug Recall Obscures Manufacturing Improvements
Massive Novartis OTC Drug Recall Obscures Manufacturing Improvements
Novartis is recalling more than 200 lots of OTC cold and flu drugs distributed in seven countries — a massive market correction by the company beset with quality problems at its OTC plants since 2012.